BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6256616)

  • 1. [Isocyanate pathology: immunological diagnostic methods (author's transl)].
    Nava C; Briatico-Vangosa G
    Med Lav; 1980; 71(4):305-11. PubMed ID: 6256616
    [No Abstract]   [Full Text] [Related]  

  • 2. 2,4- and 2,6-toluene diisocyanates, 1,5-naphthalene diisocyanate, 4,4-methylenediphenyl diisocyanate and polymethylene polyphenyl isocyanate and flexible and rigid polyurethane foams.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Feb; 19():303-40. PubMed ID: 220177
    [No Abstract]   [Full Text] [Related]  

  • 3. Isocyanate induced asthma.
    Butcher BT
    Eur J Respir Dis Suppl; 1982; 123():78-81. PubMed ID: 6297947
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental model of asthma by toluene diisocyanate (TDI).
    Tanaka K; Kawai M; Maekawa N
    Bull Chest Dis Res Inst Kyoto Univ; 1983 Mar; 16(1-2):1-9. PubMed ID: 6317089
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isocyanates: adverse effects on health].
    Mapp CE
    Med Lav; 1991; 82(4):328-35. PubMed ID: 1661832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic sensitization and pulmonary hypersensitivity by repeated inhalation of aromatic isocyanates.
    Karol MH; Dixon C; Brady M; Alarie Y
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):260-70. PubMed ID: 6249000
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensory irritation, pulmonary irritation, and acute lethality of a polymeric isocyanate and sensory irritation of 2,6-toleune diisocyanate.
    Weyel DA; Rodney BS; Alarie Y
    Toxicol Appl Pharmacol; 1982 Jul; 64(3):423-30. PubMed ID: 6291194
    [No Abstract]   [Full Text] [Related]  

  • 8. Isocyanate-induced respiratory disease.
    Banks DE; Butcher BT; Salvaggio JE
    Ann Allergy; 1986 Dec; 57(6):389-96. PubMed ID: 3024527
    [No Abstract]   [Full Text] [Related]  

  • 9. Toluene diisocyanate.
    Burge PS; Taylor AJ; Harries MG; O'Brien I
    Lancet; 1978 Jul; 2(8080):96-7. PubMed ID: 78315
    [No Abstract]   [Full Text] [Related]  

  • 10. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.
    Robins J; Greaves IA; Eisen EA
    Am Rev Respir Dis; 1983 Aug; 128(2):327-8. PubMed ID: 6309046
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences of opinion over TDI.
    Hopkins J
    Food Cosmet Toxicol; 1980 Apr; 18(2):199. PubMed ID: 6248443
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of isocyanate sensitisation. An in vitro approach.
    Elms J; Beckett PN; Griffin P; Curran AD
    Toxicol In Vitro; 2001 Dec; 15(6):631-4. PubMed ID: 11698162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the pathogenesis of isocyanate-induced asthma].
    Baur X; Römmelt H; Fruhmann G
    Respiration; 1979; 38(5):289-98. PubMed ID: 231808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cholinesterase activity by isocyanates.
    Brown WE; Green AH; Karol MH; Alarie YC
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):45-52. PubMed ID: 6280343
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicology, industrial hygiene and medical control of TDI, MDI and PMPPI.
    Woolrich PF
    Am Ind Hyg Assoc J; 1982 Feb; 43(2):89-97. PubMed ID: 6277173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of anti-dsDNA autoantibody concentration in sera of workers occupationally exposed to diisocyanates.
    Czuppon AB; Marczynski B; Scheer E; Hartmann R; Baur X
    Toxicol Lett; 1993 Jan; 66(1):29-34. PubMed ID: 8381243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity.
    Karol MH
    Ann Allergy; 1991 Jun; 66(6):485-9. PubMed ID: 1646579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchial asthma presumably caused by isocyanate in "Yamanaka, Japan-Ware" workers (author's transl)].
    Yamada Y; Okada A
    Sangyo Igaku; 1978 Mar; 20(2):116-7. PubMed ID: 211303
    [No Abstract]   [Full Text] [Related]  

  • 19. Massachusetts experience with toluene di-isocyanate.
    ELKINS HB; McCARL GW; BRUGSCH HG; FAHY JP
    Am Ind Hyg Assoc J; 1962; 23():265-72. PubMed ID: 13889881
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs.
    Karol MH; Hauth BA; Riley EJ; Magreni CM
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):221-30. PubMed ID: 6264649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.